Emergence of Aureobasidium pullulans as human fungal pathogen and molecular assay for future medical diagnosis

. 2011 Sep ; 56 (5) : 459-67. [epub] 20110910

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid21909832

Despite the great importance of Aureobasidium pullulans in biotechnology, the fungus had emerged as an opportunistic human pathogen, especially among immunocompromised patients. Clinical detection of this rare human fungal pathogen presently relies on morphology diagnosis which may be misleading. Thus, a sensitive and accurate quantitative molecular assay for A. pullulans remains lacking. In this study, we presented the microscopy observations of A. pullulans that reveals the phenotypic plasticity of the fungus. A. pullulans-specific primers and molecular beacon probes were designed based on the fungal 18S ribosomal RNA (rRNA) gene. Comparison of two probes with varied quencher chemistry, namely BHQ-1 and Tamra, revealed high amplification efficiency of 104% and 108%, respectively. The optimized quantitative real-time PCR (qPCR) assays could detect and quantify up to 1 pg concentration of A. pullulans DNA. Both assays displayed satisfactory performance parameters at fast thermal cycling mode. The molecular assay has great potential as a molecular diagnosis tool for early detection of fungal infection caused by A. pullulans, which merits future study in clinical diagnosis.

Zobrazit více v PubMed

Methods Mol Biol. 2000;132:365-86 PubMed

Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W577-81 PubMed

Infect Control Hosp Epidemiol. 2000 Jul;21(7):470-2 PubMed

J Clin Microbiol. 1986 May;23(5):828-31 PubMed

Bone Marrow Transplant. 2010 Jan;45(1):203-4 PubMed

J Antimicrob Chemother. 2008 Jan;61 Suppl 1:i3-6 PubMed

J Clin Microbiol. 2008 Jun;46(6):1919-26 PubMed

Appl Environ Microbiol. 2003 Sep;69(9):5622-6 PubMed

Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 PubMed

Appl Environ Microbiol. 2003 Sep;69(9):5389-97 PubMed

Clin Exp Ophthalmol. 2006 Apr;34(3):260-4 PubMed

Appl Microbiol Biotechnol. 2009 Apr;82(5):793-804 PubMed

Biotechnol Lett. 2011 Jun;33(6):1151-7 PubMed

Clin Exp Dermatol. 2009 Dec;34(8):e892-4 PubMed

Arch Dermatol. 1997 May;133(5):663-4 PubMed

Diagn Microbiol Infect Dis. 2005 Mar;51(3):209-13 PubMed

Int J Infect Dis. 2008 Nov;12(6):e137-9 PubMed

Stud Mycol. 2008;61:21-38 PubMed

Mycologia. 2009 Nov-Dec;101(6):823-32 PubMed

J Clin Microbiol. 2003 Sep;41(9):4483-5 PubMed

Pathology. 1987 Jul;19(3):281-4 PubMed

Mycopathol Mycol Appl. 1959 Dec 30;12:1-45 PubMed

Arch Ophthalmol. 1974 Dec;92(6):529-30 PubMed

Ann Allergy Asthma Immunol. 2007 Feb;98(2):153-6 PubMed

J Agric Food Chem. 2007 May 30;55(11):4312-8 PubMed

Appl Environ Microbiol. 2011 Mar;77(6):2188-91 PubMed

Am J Nephrol. 1995;15(4):353-5 PubMed

Clin Microbiol Rev. 2011 Apr;24(2):247-80 PubMed

Appl Environ Microbiol. 1996 May;62(5):1514-8 PubMed

Int Arch Allergy Immunol. 2006;139(1):45-52 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

The current status of Aureobasidium pullulans in biotechnology

. 2018 Mar ; 63 (2) : 129-140. [epub] 20171027

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...